Investigational Drug Program
BC Cancer's Investigational Drug Program (IDP) provides fee-for-service preclinical research services and contract manufacturing for academic and private-sector researchers. IDP’s mandate is to help its research partners develop promising therapeutic compounds to the point where they can be tested in early phase human clinical trials.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.